[Drug Excipients. Necessary, but not Harmless]. [PDF]
López Alarcón MD +2 more
europepmc +1 more source
[Therapeutic indications in lawsuits seeking medical Cannabis in Brazil: a cross-sectional study in light of scientific evidence]. [PDF]
Pinto CDBS +5 more
europepmc +1 more source
[Evaluation of pharmaceutical intervention to patients in the community through telepharmacy]. [PDF]
Delgado-Pérez GM +4 more
europepmc +1 more source
Virological failure in HIV-naïve patients with antiretroviral therapy: A perspective from pharmacological variables [PDF]
Gómez-Mercado CA +5 more
europepmc +1 more source
Treatment of Heart Failure in Brazil: Where Cost-Effectiveness Studies and Public Access Data to Therapies MeetReplyCost-Effectiveness of Therapies for Heart Failure in Brazil: A Systematic Review. [PDF]
Garbin HI, Scolari FL, Biolo A.
europepmc +1 more source
Controversies in neuroimmunology: Multiple sclerosis and other demyelinating disorders [PDF]
Villegas AC +12 more
europepmc +1 more source
Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024. [PDF]
Silva SN, Saliba MF, Ribeiro LR, Cota G.
europepmc +1 more source
[Drug shortages in Family Medicine practice]. [PDF]
Esteban-Jiménez Ó +1 more
europepmc +1 more source
Care and primary health care access indicators among Brazilian adults with diabetes mellitus, National Health Survey 2019. [PDF]
Tonaco LAB +4 more
europepmc +1 more source

